Pohler, A.; Abdelfatah, S.; Riedl, M.; Meesters, C.; Hildebrandt, A.; Efferth, T.
Potential Coronaviral Inhibitors of the Nucleocapsid Protein Identified In Silico and In Vitro from a Large Natural Product Library. Pharmaceuticals 2022, 15, 1046.
https://doi.org/10.3390/ph15091046
AMA Style
Pohler A, Abdelfatah S, Riedl M, Meesters C, Hildebrandt A, Efferth T.
Potential Coronaviral Inhibitors of the Nucleocapsid Protein Identified In Silico and In Vitro from a Large Natural Product Library. Pharmaceuticals. 2022; 15(9):1046.
https://doi.org/10.3390/ph15091046
Chicago/Turabian Style
Pohler, Alexandra, Sara Abdelfatah, Max Riedl, Christian Meesters, Andreas Hildebrandt, and Thomas Efferth.
2022. "Potential Coronaviral Inhibitors of the Nucleocapsid Protein Identified In Silico and In Vitro from a Large Natural Product Library" Pharmaceuticals 15, no. 9: 1046.
https://doi.org/10.3390/ph15091046
APA Style
Pohler, A., Abdelfatah, S., Riedl, M., Meesters, C., Hildebrandt, A., & Efferth, T.
(2022). Potential Coronaviral Inhibitors of the Nucleocapsid Protein Identified In Silico and In Vitro from a Large Natural Product Library. Pharmaceuticals, 15(9), 1046.
https://doi.org/10.3390/ph15091046